Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241531 Viral fibers
10/02/2008US20080241268 Compositions and methods for wt1 specific immunotherapy
10/02/2008US20080241260 Compositions for Enhanced Absorption of Biologically Active Agents
10/02/2008US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
10/02/2008US20080241244 Combining with such as potassium phosphate buffer solution containing sucrose, gelatin and ethylene oxide-propylene oxide copolymer; cooling, expanding then evaporation or sublimation drying; shelf life
10/02/2008US20080241233 In large unilamellar lipid vesicles containing phosphatidylserine, procoagulant phospholipid, proteins having binding affinity for collagen, human platelet glycoprotein Ib or Von Willebrands Factor, and a phospholipid scramblase; thrombocytopenia, chemotherapy, surgery or injury
10/02/2008US20080241196 Invasin complex comprising lipopolysaccharide component from gramnegative bacteria for use as tool to facilitate transport of biomolecules, therapeutics and antibiotics across cell membranes
10/02/2008US20080241195 Optimal Polyvalent Vaccine for Cancer
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241193 An expression vector for Leishmania kinetoplastid membrane protein 11 antigen or an epitope thereof, from a recombinant canarypox virus; prime-boost administration regimen; prevents diffusion and implantation of parasite into internal organs
10/02/2008US20080241192 Cross-protective immunity in cattle and poultry; administering a mutant P. multocida that is acapsular or attenuated
10/02/2008US20080241191 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/02/2008US20080241190 Vaccination of horses against lawsonia intracellularis
10/02/2008US20080241189 Sequential oral, intranasal, or intramuscular administration of a replication-defective adenovirus comprising a first heterologous expression cassette, and an adeno-associated virus comprising a second heterologous expression cassette; side effect reduction in vaccine carriers
10/02/2008US20080241188 Namely the hemagglutinin gene under control of the cytomegalovirus immediate early promoter; inoculating chickens; serological responses are easily detected by hemagglutination inhibition assay but not by diagnostic ELISA kits, enabling differentiation between vaccination and field infection
10/02/2008US20080241187 Stabilization of viral compositions
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241185 A matrix of a crosslinked polyampholyte having a cavity capable of selectively binding to a template of microorganisms, bacteria, proteins, nucleic acids; cartridges for blood dialysis (HIV); purification by washing a chromatography column loaded with a cell/tissue extracted virus followed by elution
10/02/2008US20080241184 Canine influenza vaccines
10/02/2008US20080241183 Tetanus toxoids; polyclonal antibodies; antigens
10/02/2008US20080241182 Mycobacterial polypeptide for use in producing vaccine to prevent grampositive bacterial infection
10/02/2008US20080241181 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
10/02/2008US20080241180 Immunogenic composition which induces bactericidal immune response towards neisseria
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241178 Novel human gene functionally related to dyslexia
10/02/2008US20080241177 Idiotypic vaccine
10/02/2008US20080241176 Incubating monocytes in nutrient broth comprising interleukins, cytokine and modified nucleotide sequences; propagate cells; recover antigen-presenting dendritic cell, contact with t-lymphocyte
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241174 Lymphocyte which constitutively express cell surface markers CD4 and CD25, secretes cytokines interleukin-10 and interferon-gamma for use in ameloriating graft rejection and autoimmunity
10/02/2008US20080241173 Using FLT3 kinase as tool in identifying modulators for treatment and prevention of hematopoietic stem cell disease
10/02/2008US20080241172 Mutated Cholinesterase Sequences, Corresponding Nucleic Acids And Their Uses
10/02/2008US20080241170 Increasing effectiveness of antigen cells expressing dendritic cell inhibitory receptor (DCIR); tissue targeted therapy
10/02/2008US20080241169 Using phage displayed prion specific immunoglobulin to prevent aggregation of amyloid plaques; treating alzheimer's disease
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241166 Ligands that bind a receptor
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241164 BMP-3 antibodies and related methods
10/02/2008US20080241163 Tweak binding antibodies
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241161 Liposome encapsulated antitumor immunoglobulin fusion for use in treatment of breast cell proliferative disorders
10/02/2008US20080241160 Interleukin-4 specific immunoglobulin for use in treatment and prevention of atopic, respiratory and allergic disorders
10/02/2008US20080241159 Methods and compositions for selective modulation of vascularization
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241157 Nerve cell growth modulators (amphibodies)
10/02/2008US20080241156 Inhibitors of hepatitis C virus
10/02/2008US20080241155 Death domain containing receptor 4
10/02/2008US20080241154 Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241149 Antibodies to complementary peptides of thrombin or portions thereof
10/02/2008US20080241148 Treatment with anti-vegf antibodies
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241145 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241142 Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
10/02/2008US20080241141 Using multispecific antagonist for use in treatment and prevention of infection, cell proliferative, inflammatory and autoimmune disorders
10/02/2008US20080241140 Gene amplification of coactivator coaa and uses thereof
10/02/2008US20080241139 Therapeutic mixture comprising toll-like receptor, CD40 and tumor necrosis factor agonist for use in treatment and prevention of cell proliferative and viral diseases
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241137 Cancerous disease modifying antibodies
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241135 Using humanized monoclonal antibody (POR140) as therapeutic to decrease viral particles in human immunodeficiency virus infected individuals; viricides; enzyme inhibitors
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241132 Using serine/threonine kinase inhibitors to treat cell proliferative disorders
10/02/2008US20080241131 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
10/02/2008US20080241130 Methods and compositions for modulating il-17f/il-17a biological activity
10/02/2008US20080241129 Adipocyte secreted protein ccdc80 is a potent stimulator of bone formation
10/02/2008US20080241128 Antibodies; anticancer agents; autoimmune disorders
10/02/2008US20080241127 Screening antibody display library for infection specific immnoglobulins
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241125 Muc1-ikb kinase complexes and their activities
10/02/2008US20080241124 Nucleotide sequences coding g-protein couple receptor for use in identifying modulators for prevention and treatment of inflammation, sarcoidosis and rheumatoid arthritis
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241075 Parasite Vaccine
10/02/2008US20080241069 Methods and compositions for treating IgE-mediated diseases
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241066 Anti-PRL-3 antibodies and methods of use thereof
10/02/2008US20080241064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/02/2008US20080241062 Cancerous disease modifying antibodies
10/02/2008US20080237905 Preparation of polyphosphazene microspheres
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2719522A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
10/02/2008CA2717659A1 Therapeutic applications of activation of human antigen-presenting cells through dectin-1
10/02/2008CA2685729A1 Artificial invaplex
10/02/2008CA2682654A1 Probiotics to improve gut microbiota
10/02/2008CA2682206A1 Acute transmitted hiv envelope signatures
10/02/2008CA2682054A1 Use of an adjuvanted allergy vaccine formulation for parenteral administration
10/02/2008CA2682047A1 Compositions and methods for increasing immunogenicity of glycoprotein vaccines
10/02/2008CA2682045A1 Method of eliciting immune response with a modified mva viral hiv-1 vector
10/02/2008CA2682027A1 Modulation of tumor microenvironment
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681851A1 Combined human il-18 and anticd20 antibody cancer treatment
1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 1823